Diet and breast cancer: Understanding risks and benefits

Nutrition in Clinical Practice

Volumn 27, Issue 5, 2012, Pages 636-650

  Thomson, Cynthia A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Breast neoplasms; Diet; Dietary fats; Dietary fiber; Obesity; Prevention; Survival

Indexed keywords

ALCOHOL; AROMATASE INHIBITOR; BEVACIZUMAB; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; OMEGA 3 FATTY ACID; PACLITAXEL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; ESTROGEN;

BODY WEIGHT; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; DIET; DIETARY FIBER; FAT INTAKE; FATIGUE; FRACTURE; FRUIT; HIGH FIBER DIET; HOT FLUSH; HUMAN; INSOMNIA; LEGUME; LOW FAT DIET; MEAT; MULTIMODALITY CANCER THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; TREATMENT RESPONSE; VEGETABLE; WEIGHT CHANGE; WEIGHT CONTROL; WEIGHT GAIN; BREAST TUMOR; CALORIC INTAKE; DRINKING BEHAVIOR; FEMALE; METABOLISM; OBESITY; POSTMENOPAUSE; SURVIVOR;

ALCOHOL DRINKING; BREAST NEOPLASMS; DIET; DIETARY FIBER; ENERGY INTAKE; ESTROGENS; FEMALE; HUMANS; OBESITY; POSTMENOPAUSE; SURVIVORS;

EID: 84872423506     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612454302     Document Type: Review

References (108)

1. American Cancer Society. Breast cancer facts & figures 2011-2012. http://www.cancer org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-030975.pdf. Accessed March 18, 2012.
2. American Cancer Society. Facts & figures 2011; surveillance research. http://www.cancer. Org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-029771.pdf. Accessed March 18, 2012.
3. Howlader N. SEER cancer statistics review, 1975-2008. 2010. http://seer. cancer.gov/csr/1975-2008/. Accessed March 18, 2012.
4. Mullan PB, Millikan RC. Molecular subtyping of breast cancer: opportunities for new therapeutic approaches. Cell Mol Life Sci. 2007;64(24):3219-3232.
5. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30-67.
6. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.
7. Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884-1890.
8. Li CL, Chlebowski RT, Freiberg M, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the Women's Health Initiative observational study. J Natl Cancer Inst. 2010;102(18):1422-1431.
9. Kabat GC, Kim M, Phipps AL, et al. Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control. 2011;22(5):775-783.
10. Dennis J, Ghadirian P, Little J, et al. Alcohol consumption and the risk of breast cancer among BRCAI and BRCA2 mutation carriers. Breast. 2010;19(6):479-483.
11. Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer. JAMA. 1999;281(17):1632-1637.
12. Tao MH, Marian C, Shields PG, et al. Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol. 2011;45(7):689-699.
13. Purohit V. Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res. 1998;22(5):994-997.
14. Crider KS, Bailey LB, Berry RJ. Folic acid food fortification: its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370-384.
15. Ritenbaugh C, Patterson RE, Chlebowski RT, et al. The Women's Health Initiative Dietary Modification Trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(9) (suppl):S87-S97.
16. Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):629-642.
17. Prentice RL, Shaw PA, Bingham SA, et al. Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol. 2009;169(8):977-989.
18. Tinker LF, Rosal MC, Young AF, et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. JAm Diet Assoc. 2007;107(7):1155-1166.
19. Martin LJ, Li Q, Melnichouk O, et al. A randomized trial of dietary intervention for breast cancer prevention. Cancer Res. 2011;71(1);123-133.
20. Turner LB. A meta-analysis of fat intake, reproduction, and breast cancer risk: an evolutionary perspective. Am J Hum Biol. 2011;23:601-608.
21. Wirfait E, Li C, Manjer J, et al. Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the Malmo diet and cancer cohort. Nutr Cancer. 2011;63(5):722-733.
22. Schulz M, Hoffmann K, Weikert C, Nothlings U, Schulze MB, Boeing H. Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 2008;100(5):942-946.
23. Young LR, Kurzer MS, Thomas W, Redmon JB, Raatz SK. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: a randomized controlled feeding trial. Nutr Cancer. 2011;63(6):930-939.
24. Howard BV, Manson JE, Stefanik ML, et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA. 2006;296(4):394-395.
25. Alexander DD, Morimoto LM, Mink PJ, Cushing CA. A review and metaanalysis of red and processed meat consumption and breast cancer. Nutr Res Rev. 2010;23(2):349-365.
26. Rock CL, Flatt SW, Thomson CA, et al. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol. 2004;22(12):2379-2387.
27. Dong J, He K, Wang P, Qin LQ. Dietary fiber intake and risk breast cancer: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;94(3):900-905.
28. He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer [published online November 22, 2011]. Ann Oncol, doi: 10.1093/annonc/mdr534.
29. Track BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98(7):459-471.
30. Thomson CA, Thompson PA. Dietary patterns and breast cancer prognosis: a review of current evidence. Future Oncol. 2009;5(8):1257-1269.
31. Prieto-Ramos F, Serra-Majem L, La Vecchia C, Ramon JM, Tresserras R, Salleras L. Mortality trends and past and current dietary factors of breast cancer in Spain. Eur J Epidemiol. 1996;12(2):141-148.
32. Colomer R, Menendez JA. Mediterranean diet, olive oil and cancer. Clin Transl Oncol. 2006;8(1):15-21.
33. Carruba G, Granata OM, Pala V, et al. A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutr Cancer. 2006;56(2):253-259.
34. Kotsopoulos J, Olopado OI, Ghadirian P, et al. Changes in body weight and the risk of breast cancer in BRCAI and BRCA2 mutation carriers. Breast Cancer Res. 2005;7(5):R833-R843.
35. Nkondjock A, Ghadirian P. Diet quality and BRCA-associated breast can-51. cer risk. Breast Cancer Res Treat. 2007;103(3):361-369.
36. Phipps AL, Malone KE, Porter PL, Daling JR, Li CL. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2078-2086.
37. Sutton-Tyrrell K, Zhao X, Santoro N, et al. Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol. 2010;171(11):1203-1213.
38. Zhu Z, Jiang W, Zacher JH, Neil ES, McGinley JN, Thompson HJ. Effects of energy restriction and wheel running on mammary carcinogenesis and host systematic factors in a rat model. Cancer Prev Res. 2012;5(3):414-422.
39. Connolly BS, Bamett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer. 2002;44(2):127-138.
40. Vrieling A, Buck K, Kaaks R, et al. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat. 2010;123:641-649.
41. Elliott LG, Molseed LL, McCallum PD, Grant B. The Clinical Guide to Oncology Nutrition. 2nd ed. Chicago, IL: American Dietetic Association; 2006.
42. Saquib N, Flatt SW, Natarajan L, et al. Weight gain and recovery of precancer weight after breast cancer treatments: evidence from the Women's Healthy Eating and Living (WHEL) study. Breast Cancer. Res Treat. 2007;105(2):177-186.
43. Gadea E, Thivat E, Planchat E, Morio B, Durando X. Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms. Obes Rev. 2012;13(4):368-380.
44. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19(9):2381-2389.
45. Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol. 2002;4(1):44-49.
46. Fujita S, Volpi E. Amino acids and muscle loss with aging. J Nutr. 2006;136(1) (suppl):277S-280S.
47. Peters SJ, Van Helvoort A, Kegler D, et al. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice. Oncol Rep. 2011;26(1):247-254.
48. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009;12(1):86-90.
49. Amir E, Seruga B, Niraula S, et al. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and metaanalysis. J Natl Cancer Inst. 2011;103(17):1299-1309.
50. Thomson CA, Rock CL, Thompson PA, et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat. 2011;125(2):519-527.
51. Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009;118(2):395-405.
52. Rock CL, Doyle D, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors [published online April >26, 2012]. CA Cancer J Clin. doi:10.3322/caac.21142.
53. Majed B, Moreau T, Asselain B. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points. Breast Cancer Res Treat. 2009;115(1):193-203.
54. Dawood S, Broglio K, Gonzalez-Angulo AM, et al. Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res. 2008;14(6):1718-1725.
55. Dignam JJ, Mamounas EP. Obesity and breast cancer prognosis: an expanding body of evidence. Ann Oncol. 2004;15(6):850-851.
56. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370-1378.
57. Caan BJ, Kwan ML, Hartzell G, et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008;19(10):1319-1328.
58. Kuerer HM, Lari SA, Aran BK, et al. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass [published online March 4, 2012]. Breast Cancer Res Treat. doi: 10.1007/sl 0549-012-1999-3.
59. Kwan ML, Chen WY, Kroenke CH, et al. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012;132(2):729-739.
60. Majed B, Dozol A, Ribassin-Majed L, Senouci K, Asselain B. Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association. Breast Cancer Res Treat. 2011;126(3):729-738.
61. Dignam JJ, Wieand K, Johnson KA, et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat. 2006;97(3):245-254.
62. Dignam JJ, Wieand K, Johnson KA, et al. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. JNCI. 2003;95(19):1467-1476.
63. Li CL, Daling JR, Porter PL, Tang MT, Malone KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptorpositive invasive breast cancer. J Clin Oncol. 2009;27(32):5312-5318.
64. Abrahamson PE, Gammon MD, Lund MJ, et al. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1871-1877.
65. Barnett GC, Shah M, Redman K, et al. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol. 2008;26(20):3310-3316.
66. Moon HG, Han W, Noh DY. Underweight and breast cancer recurrence and death: report from the Korean Breast Cancer Society. J Clin Oncol. 2009;27(35):5899-5905.
67. Patterson RE, Flatt SW, Saquib N, et al. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. 2010;122(3):859-865.
68. Thomson CA, Thompson PA, Wright-Bea L, Nardi E, Frey GR, Stopeck A. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt). 2009;18(12):2041-7.
69. Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care. 2012;35(2):299-304.
70. Kaplan MA, Pekkolay Z, Kucukoner M, et al. Type 2 diabetes mellitus and prognosis in early stage breast cancer women [published online November 15, 2011]. Med Oncol, doi: 10.1200/JC0.2010.29.3183.
71. Pierce JP. Diet and breast cancer prognosis: making sense of the Women's Healthy Eating and Living and Women's Intervention Nutrition Study trials. Curr Opin Obestet Gynecol. 2009;21(1):86-91.
72. Chlebowski RT, Rose D, Buzzard IM, et al. Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management: the Women's Intervention Nutrition Study (WINS). Breast Cancer Res Treat. 1992;20(2):73-84.
73. Chlebowski R, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results for the Women's Intervention Nutrition Study (WINS). J Natl Cancer Inst. 2006;98(24):1767-1776.
74. Heber D. Interrelationships of high fat diets, obesity, hormones, and cancer. Adv Exp Med Biol. 1996;399:13-25.
75. Saxe GA, Rock CL, Wicha MS, et al. Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat. 1999;53:241-253.
76. Beasley JM, Newcomb PA, Trentham-Dietz A, et al. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011;128(1):229-236.
77. Rohan TE, Hiller JE, McMichael AJ. Dietary factors and survival from breast cancer. Nutr Cancer. 1993;20(2):167-177.
78. Kroenke CH, Fung TT, Hu FB, et al. Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(5):9295-9303.
79. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007;298(3):289-298.
80. Pierce JP, Faerber S, Wright FA, et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) study. Control Clin Trials. 2002;23(6):728-756.
81. Rock CL, Flatt SW, Natarajan L, et al. Plasma carotenoids and recurrencefree survival in women with a history of breast cancer. J Clin Oncol. 2005;23(27):6631-6638.
82. Rock CL, Natarajan L, Pu M, et al. Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study. Cancer Epidemiol Biomarkers Prev. 2009;18(2):486-494.
83. Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival after breast cancer in physically active women with high vegetable-frait intake regardless of obesity. J Clin Oncol. 2007;25(17):2345-2351.
84. Rock CL, Flatt SW, Laughlin GA, et al. Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(3). 614-620.
85. Belle FN, Kampman E, McTieman A, et al. Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev. 2011;20(5):890-899.
86. Patterson RE, Flatt SW, Newman VA, et al. Marine fatty acid intake is associated with breast cancer prognosis. JNutr. 2011;141(2):201-206.
87. Caan B, Natarajan L, Parker B et al. Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2011;20(5):854-858.
88. Kang X, Zhang Q, Wang S, Huang X, Jin S. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ. 2010;182(17):1857-1862.
89. Jacobs ET, Thomson CA, Flatt SW, et al. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) study. Am J Clin Nutr. 2011;93(1):108-117.
90. Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC. Dietary factors and the survival of women with breast carcinoma. Cancer. 1999;86(5):826-835.
91. Jain M, Miller AB, To T. Premorbid diet and the prognosis of women with breast cancer. JNatl Cancer Inst. 1994;86(18):1390-1397.
92. George SM, Neuhouser ML, Mayne ST, et al. Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2220-2228.
93. Kwan ML, Weltzien E, Kushi LH, et al. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009;27(6):919-926.
94. Kim EH, Willett WC, Fung T, Rosner B, Holmes MD. Diet quality indices and postmenopausal breast cancer survival. Nutr Cancer. 2011;63(3):381-388.
95. Kwan ML, Kushi LH, Weltzien E, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the Life After Cancer Epidemiology study. J Clin Oncol. 2010;28(29):4410-4416.
96. Flatt SW, Thomson CA, Gold EB, et al. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(3):681-688.
97. Allemani C, Berrino F, Krogh V, et al. Do pre-diagnostic drinking habits influence breast cancer survival? Tumori. 2011;97(2):142-148.
98. Thomson CA, Stopeck AT, Bea JW, et al. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low fat vs reduced carbohydrate diet. Nutr Cancer. 2010;62(8):1142-1152.
99. Thompson HJ, Sedlacek SM, Paul D, et al. Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors. Breast Cancer Res. 2012;14(1):R1.
100. Thomson CA, Flatt SW, Rock CL, Ritenbaugh C, Newman V, Pierce JP. Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer. J Am Diet Assoc. 2002;102:801-808.
101. Wayne SJ, Lopez ST, Butler LM, Baumgartner KB, Baumgartner RM, Ballard-Barbash R. Changes in dietary intake after diagnosis of breast cancer. J Am Diet Assoc. 2004;104(10):1561-1568.
102. Christy SM, Mosher CE, Sloane R, Snyder DC, Lobach DF, Demark-Wahnefried W. Long-term dietary outcomes of the FRESH START intervention for breast and prostate cancer survivors. J Am Diet Assoc. 2011;111(12):1844-1851.
103. Thomson CA, Stendell-Hollis NR, Rock CL, Cussler EC, Flatt SW, Pierce JP. Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2008-2015.
104. Gold EB, Pierce JP, Natarajan L, Stefanick ML, et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: the Women's Healthy Eating and Living (WHEL) trial. J Clin Oncol. 2009;27(3):352-359.
105. Snyder DC, Morey MC, Sloane R, et al. Reach out to ENhancE Wellness in Older Cancer Survivors (RENEW): design, methods and recruitment challenges of a home-based exercise and diet intervention to improve physical function among long-term survivors of breast, prostate, and colorectal cancer. Psycho-Oncology. 2009;18(4):429-439.
106. Demark-Wahnefried W, Morey MC, Clipp EC, et al. Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials. 2003;24(2):206-223.
107. Demark-Wahnefried, Clipp EC, Lipkus IM, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007;26(19):2709-2718.
108. Sedlacek SM, Playdon MC, Wolfe P, et al. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol. BMC Cancer. 2011;11:287.